Kuveda
WHO: Chuck Gershman
WHEN: Founded in 2014
WHERE: San Jose, United States of America
RING EXPERIENCE: Pilot Contract Winner with HTXL - Philips
With recent advancements in molecular biology, it is now possible to uniquely identify specific genetic and molecular variations of a patient’s individual tumor. Known as a tumor profile, this profile can be used as the basis to formulate treatment plans that target the molecular structures that may be driving an individual patient’s unique cancer.
WHO: Chuck Gershman
WHEN: Founded in 2014
WHERE: San Jose, United States of America
RING EXPERIENCE: Pilot Contract Winner with HTXL - Philips